Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedThe page now displays an updated revision tag from v3.6.0 to v3.6.2, indicating a minor version update to the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to not recruiting; new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label formatting plus a Revision: v3.6.0 tag were updated.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision number was updated from v3.5.4 to v3.5.5, indicating a new release of the page content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, representing a new version of the page. This change is a metadata update and does not modify the study content, eligibility criteria, or listed results.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision has been updated from v3.5.2 to v3.5.3. This indicates a new revision of the page content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.